Oral Versus Injectable Therapies in Psoriasis: Beyond Route to Molecular Modality and Pharmacologic Determinants [0.03%]
口服与注射类药物治疗银屑病：超越给药途径，重视分子机制和药物学特点
Michael H Gold,Mohamad Goldust
Michael H Gold
Evidence of Increased 3-Alpha-Androstanediol Glucuronide in Female Pattern Alopecia: A Cross-Sectional Observational Study Evaluating Ovarian, Adrenal, and Peripheral Androgens [0.03%]
女性型脱发中3α-雄烷二醇葡萄糖苷水平升高：一项评估卵巢、肾上腺及外周雄激素的横断面观察研究
Arunesh Padmini Kathirvelu,Kabir Sardana,Lokesh Kumar Sharma et al.
Arunesh Padmini Kathirvelu et al.
Background: The role of androgens in female pattern hair loss (FPHL) is disputed as patients usually have normal androgen levels. 3α-androstanediol glucuronide (3α-diol G) is a marker of peripheral hyperandrogenism, but...
Diagnostic Accuracy of Three Large Language Models on Clinical Images Varies by Skin Tone: Findings From the Stanford Diverse Dermatology Images Dataset [0.03%]
三种大型语言模型在临床图像上的诊断准确性因肤色而异：来自斯坦福多元皮肤科图像数据集的研究发现
Eunice Y Ju,Ahana Sinharoy,Nicole Edmonds et al.
Eunice Y Ju et al.
Real-World Evidence of Dupilumab's Efficacy in Reducing Autoantibodies to Bullous Pemphigoid Antigens [0.03%]
关于杜匹鲁单抗减少大疱性天疱疮自身抗体疗效的真实世界证据
Kateryna Karpoff,Anya Patel,Georgina Erfe et al.
Kateryna Karpoff et al.
Lajos Kemény
Lajos Kemény
Major advances have broadened the therapeutic landscape of inflammatory skin diseases. In psoriasis, alongside the tyrosine kinase 2 (TYK2) inhibitor deucravacitinib, the United States Food and Drug Administration (FDA) has approved the fir...
Trichoscopy of Cicatricial Alopecia in Fair and Dark Skin: A Multicenter International Study of the EADV Task Force on Hair Diseases and the IDS Task Force on Trichoscopy [0.03%]
肤色较浅和较深的瘢痕性脱发毛发镜检查：EADV毛发疾病工作组与IDS毛发镜工作组多中心国际合作研究
Awatef Kelati,Anna Waśkiel-Burnat,Zoe Apalla et al.
Awatef Kelati et al.
Background: Trichoscopy enhances diagnostic accuracy in primary cicatricial alopecias (PCA), yet comparative data on its application across diverse skin phototypes remain limited. ...
Regulatory Divergence Between United States and European Direct-to-Consumer Skin Cancer Platforms Shapes Patient Safety and Follow-Up Pathways [0.03%]
美国与欧洲针对消费者的皮肤癌平台监管差异形塑了患者的就医安全性和随访路径
Isabella Sharifi,Garrett Kraft,Keyvan Nouri
Isabella Sharifi
Efficacy of Tralokinumab in Atopic Dermatitis Patients With Prior Biologic and JAK Inhibitor Therapy [0.03%]
特纳利单抗治疗生物制剂和JAK抑制剂治疗失败的特应性皮炎患者的疗效
Alexandra Nigro,Sumanth Chennareddy,Isabel Silva et al.
Alexandra Nigro et al.
Clinical and Photobiological Response to Omalizumab in Refractory Solar Urticaria [0.03%]
难治性日光荨麻疹患者omalizumab治疗的临床和光生物学反应
Alessia Pacifico,Francesca Sperati,Norma Cameli et al.
Alessia Pacifico et al.